|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 251.58 USD | -0.51% |
|
258.66 | +2.81% |
| 03:31am | Pharma Mar Partner to File for Removal of Relapsed Small-cell Lung Cancer Indication from Zepzelca's Label in US | MT |
| 08-03 | Jazz Pharmaceuticals plc, Q2 2026 Earnings Call, Aug 03, 2026 |
| Market Cap | 15.8B 13.73B 12.82B 11.77B 22.2B 1,506B 22.58B 151B 59.22B 751B 59.36B 58.05B 2,478B | P/E 2026 * |
15.2x | P/E 2027 * | 16.4x |
|---|---|---|---|---|---|
| Enterprise Value | 17.5B 15.21B 14.2B 13.04B 24.58B 1,668B 25.01B 167B 65.58B 832B 65.74B 64.28B 2,744B | EV / Sales 2026 * |
3.88x | EV / Sales 2027 * | 3.25x |
| Free-Float |
96.66% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | -0.51% | ||
| 1 week | -1.51% | ||
| Current month | -0.51% | ||
| 1 month | +3.33% | ||
| 3 months | +24.10% | ||
| 6 months | +50.79% | ||
| Current year | +47.99% |
| 1 week | 248.45 |  | 259.75 |
| 1 month | 233.46 | | 261.3 |
| Current year | 156.95 | | 261.3 |
| 1 year | 105 | | 261.3 |
| 3 years | 95.49 | | 261.3 |
| 5 years | 95.49 | | 261.3 |
| 10 years | 86.88 | | 261.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 2025-08-10 |
Philip Johnson
DFI | Director of Finance/CFO | 62 | 2024-02-29 |
Mary Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 2023-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 2003-02-28 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 2012-01-17 |
Rick Winningham
BRD | Director/Board Member | 66 | 2009-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 | Sell | Founder | -6,000 | 0.0096% | ||
| 6/30/26 | Tax | Executive/Senior Manager | -2,527 | 0.0040% | ||
| 6/30/26 | Tax | Chief Executive Officer | -4,835 | 0.0077% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.51% | -1.51% | +117.78% | +94.20% | 15.8B | |
| -2.39% | -6.36% | +47.10% | +149.66% | 1T | |
| -0.76% | -4.34% | +52.04% | +49.09% | 613B | |
| -2.33% | -4.60% | +25.55% | +64.44% | 433B | |
| -0.13% | -3.29% | +39.53% | +34.24% | 350B | |
| +0.06% | -4.40% | +31.80% | +39.96% | 292B | |
| +1.80% | -9.30% | +5.39% | +7.57% | 239B | |
| +1.40% | -8.42% | -1.87% | -42.13% | 206B | |
| -1.63% | +0.69% | +27.62% | +64.23% | 204B | |
| +0.72% | +0.48% | +15.88% | +73.64% | 163B | |
| Average | +0.03% | -3.64% | +36.08% | +53.49% | 351.63B | |
| Weighted average by Cap. | +0.04% | -4.33% | +35.32% | +71.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.51B 3.92B 3.66B 3.36B 6.33B 430B 6.44B 43.15B 16.9B 214B 16.94B 16.56B 707B | 4.87B 4.23B 3.95B 3.62B 6.83B 464B 6.95B 46.55B 18.23B 231B 18.27B 17.87B 763B |
| Net income | 1.01B 875M 817M 750M 1.41B 95.94B 1.44B 9.63B 3.77B 47.84B 3.78B 3.7B 158B | 1.08B 935M 873M 802M 1.51B 103B 1.54B 10.3B 4.03B 51.16B 4.04B 3.95B 169B |
| Net Debt | 1.7B 1.48B 1.38B 1.26B 2.39B 162B 2.43B 16.25B 6.36B 80.72B 6.38B 6.24B 266B | 15.43M 13.41M 12.52M 11.49M 21.67M 1.47B 22.05M 148M 57.81M 733M 57.95M 56.67M 2.42B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-03 | US$251.58 | -0.51% | 1,493,478 |
| 26-07-31 | US$252.86 | -2.14% | 572,977 |
| 26-07-30 | US$258.38 | +0.94% | 728,859 |
| 26-07-29 | US$255.97 | -0.37% | 622,706 |
| 26-07-28 | US$256.92 | +0.58% | 945,212 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- JAZZ Stock
Select your edition
All financial news and data tailored to specific country editions
